secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECTIS HEALTH, INC. (GBCS)
CIK:        0000727346
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001493152-25-029572
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 2.03, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Selectis Health extends $1.775M notes to Feb 2026, interest rate raised to 13%
------------------------------------------------------------------------------

- Maturity extended to Feb 28, 2026 or earlier upon Qualified Transaction; 30-day extensions possible with 0.5% fee.
- Interest rate increased from 11% to 13% per annum effective Jan 1, 2026.
- Warrants extended to Dec 31, 2027; exercise price unchanged at $2.25 per share.
- Kent Lund and Lance Baller appointed to Board of Directors effective Jan 1, 2026.
- Solicitation fee of $9,000 paid to GVC Capital LLC in connection with the amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727346/000149315225029572/0001493152-25-029572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727346/000149315225029572/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer